510(k) Report

510(k) · Cleared

Cleared

Neurotherm RF Cannula

K994344510(k) TraditionalCleared Mar 21, 200090-day reviewClass II21 CFR 882.4725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Rocket Medical Plc · GXI Probe, Radiofrequency Lesion

Cleared on Mar 21, 2000 after a 90-day review. The FDA summary names no predicate by number. 14 later devices descend from it.

Decided
Mar 21, 2000
Review
90 days
Class
Class II
Product code
GXI
Recalls
None
Predicates
0

14 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2006: 2 descendants cleared2011: 1 descendant cleared2007: 1 descendant cleared2013: 1 descendant cleared2014: 1 descendant cleared2008: 3 descendants cleared2009: 1 descendant cleared2015: 1 descendant cleared2020: 1 descendant cleared2017: 1 descendant cleared2019: 1 descendant cleared200020052010201520202025
  1. This deviceK994344 Neurotherm RF CannulaRocket Medical Plc · 2000
  2. Descendant · cites it directly · 10 of its ownK053415 Lesionpoint RF CannulaCosman Medical, Inc. · 2006
  3. Descendant · cites it directly · 9 of its ownK060799 Cosman CSK RF Cannula; Cosman RFK RF CannulaCosman Medical, Inc. · 2006
  4. Descendant · 2 generations on · 4 of its ownK080771 Top Neuropole Needle, Model SH, BL, SC, TCTop Corp. · 2008
  5. Descendant · cites it directly · 3 of its ownK102566 Owl CannulaeDiros Technology, Inc. · 2011
  6. Descendant · 2 generations on · 3 of its ownK082012 Cosman RF Injection Electrodes, Models CU, Cur, CCD, TCD, CP, CR, CNCosman Medical, Inc. · 2008

Showing 5 of 14 descendants. See all descendants

Descendants cleared per year

2006: 22007: 12008: 32009: 12011: 12013: 12014: 12015: 12017: 12019: 12020: 1
2006high 3 (2008) · low 0 (2010)2026

Most influential descendants

Showing 5 of 14 · See all
  • K053415Lesionpoint RF CannulaCosman Medical, Inc. · 2006 · cites it directly10descendants
  • K060799Cosman CSK RF Cannula; Cosman RFK RF CannulaCosman Medical, Inc. · 2006 · cites it directly9descendants
  • K080771Top Neuropole Needle, Model SH, BL, SC, TCTop Corp. · 2008 · 2 generations on4descendants
  • K102566Owl CannulaeDiros Technology, Inc. · 2011 · cites it directly3descendants
  • K082012Cosman RF Injection Electrodes, Models CU, Cur, CCD, TCD, CP, CR, CNCosman Medical, Inc. · 2008 · 2 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K994344Neurotherm RF CannulaRocket Medical Plc2000—
+1K053415Lesionpoint RF CannulaCosman Medical, Inc.2006—
+1K060799Cosman CSK RF Cannula; Cosman RFK RF CannulaCosman Medical, Inc.2006—
+2K080771Top Neuropole Needle, Model SH, BL, SC, TCTop Corp.2008—
+1K102566Owl CannulaeDiros Technology, Inc.2011—
+2K082012Cosman RF Injection Electrodes, Models CU, Cur, CCD, TCD, CP, CR, CNCosman Medical, Inc.2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200620
200710
200830
200910
201110
201310
201410
201510
201710
201910
202010
FIG. 1 — Lineage of K994344, 2000–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXI device

  1. #1 K253907 Disposable Radiofrequency Cannulascore 12.7 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (14)

See all 14

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K053415Lesionpoint RF CannulaCosman Medical, Inc.200610
K060799Cosman CSK RF Cannula; Cosman RFK RF CannulaCosman Medical, Inc.20069
K102566Owl CannulaeDiros Technology, Inc.20113
K070443Intracept BI-Polar RF Probe, Model 04814Relievant Medsystems, Inc.20072

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K053415 (Cosman Medical, Inc., 2006) has gone furthest, with 10 descendants of its own.

How does its category compare?

All GXI devices

GXI Probe, Radiofrequency Lesion: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GXI

4in 2025

2007: 42008: 22009: 22010: 22011: 32012: 12013: 12014: 12015: 12016: 32017: 32018: 12019: 32020: 32022: 22025: 42026 (partial year): 2
2007high 4 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXI

183in 2025

2007: 87 days median2011: 64 days median2016: 240 days median2017: 125 days median2019: 63 days median2020: 255 days median2025: 183 days median
2007high 255 (2020) · low 63 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXI

1in 2019

2007: 32008: 12010: 12012: 12013: 12017: 12019: 12026 (partial year): 3
2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXI

98in 2025

2007: 12008: 42009: 102010: 82011: 52012: 142013: 252014: 202015: 232016: 162017: 1502018: 1472019: 932020: 312021: 302022: 462023: 352024: 452025: 98
2007high 150 (2017) · low 1 (2007)2025

MAUDE reports naming product code GXI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200748731
20082—14
20092—010
20102—18
201136405
20121—114
20131—125
20141—020
20151—023
20163240016
201731251150
20181—0147
2019363193
20203255031
20210—030
20222—046
20230—035
20240—045
20254183098
20262—3—

What is it indicated for?

The Neurotherm Radiofrequency Lesion cannula is indicated for use in neurosurgical lesioning procedures. Examples of these procedures include, but are not limited to, lesioning of nerve fibers for the treatment of pain and lesioning of the brain, spinal cord as in thalamotomies, pallidotomies, cordotomies and hypophysectomies,

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K994344: Neurotherm RF Cannula.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K994344

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026